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Abstract 27 
BACKGROUND: The Islamic Hajj pilgrimage to Mecca is one of the world’s largest annual 28 
mass gatherings. Inevitable overcrowding during the pilgrims’ stay greatly increases the risk 29 
of acquiring and spreading infectious diseases, especially respiratory diseases. 30 
METHOD: The MEDLINE/PubMed and Scopus databases were searched for all relevant 31 
papers published prior to February 2018 that evaluated the prevalence of clinical symptoms of 32 
respiratory infections, including pneumonia, among Hajj pilgrims, as well as their influenza 33 
and pneumococcal vaccination status. 34 
RESULTS: A total of 61 papers were included in the review. Both cohort- and hospital-based 35 
studies provide complementary data, and both are therefore necessary to provide a complete 36 
picture of the total burden of respiratory diseases during the Hajj. Respiratory symptoms have 37 
been common among Hajj pilgrims over the last 15 years. In cohorts of pilgrims, cough 38 
ranged from 1.9% to 91.5%. However, the prevalence rates of the most common symptoms 39 
(cough, sore throat, and subjective fever) of influenza-like illness (ILI) varied widely across 40 
the included studies. These studies have shown variable results, with overall rates of ILI 41 
ranging from 8% to 78.2%. These differences might result from differences in study design, 42 
study period, and rates of vaccination against seasonal influenza that ranged from 1.1% to 43 
100% among study participants. Moreover, the definition of ILI was inconsistent across 44 
studies. In hospitalized Hajj pilgrims, the prevalence of pneumonia, that remains a major 45 
concern in critically ill patients, ranged from 0.2% to 54.8%. 46 
CONCLUSIONS: Large multinational follow-up studies are recommended for clinic-based 47 
syndromic surveillance, in conjunction with microbiological surveillance. Matched cohorts 48 
ensure better comparability across studies. However, study design and data collection 49 
procedures should be standardized to facilitate reporting and to achieve comparability 50 
between studies. Furthermore, the definition of ILI, and of most common symptoms used to 51 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
3 
 
 
define respiratory infections (e.g., upper respiratory tract infection), need to be precisely 52 
defined and consistently used. Future studies need to address potential effect of influenza and 53 
pneumococcal vaccine in the context of the Hajj pilgrimage. 54 
55 
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Introduction 56 
The yearly "Hajj" (also known as the pilgrimage to Mecca) in the Kingdom of Saudi Arabia 57 
(KSA) is the "Fifth Pillar of Islam" and is mandatory once in a lifetime for all adult Muslim 58 
who are physically and financially able. The Hajj is one of the world’s largest annual mass 59 
gatherings. In 2016, around 1.3 million foreign visitors, from more than 180 countries, 60 
gathered in the KSA to complete the Hajj, in addition to over 500,000 domestic Hajj pilgrims 61 
[1]. Also, about 5-6 million pilgrims perform the "Umrah" (also known as the lesser 62 
pilgrimage) each year. 63 
The Hajj and its rituals are physically demanding for Hajj pilgrims, the majority of whom are 64 
elderly [2], with chronic conditions. Although the Hajj rituals only take one week, pilgrims 65 
usually stay in the KSA for several weeks throughout the month-long Hajj season, presenting 66 
a major public health and infection control concern, and a challenge both for the Saudi 67 
authorities, as well as for the national authorities of the countries of origin of the pilgrims. In 68 
addition to physical exhaustion, sleep deprivation [3], and heat stress [4], inevitable 69 
overcrowding, both in housing and ritual sites, especially in Mina encampment (this is 70 
approximately a 3-kilometer square area where pilgrims are accommodated in air-conditioned 71 
semi-permanent tents, some with up to 50-100 people) and inside the Sacred Mosque in 72 
Mecca (with up to six pilgrims per square meter) [5], greatly increases the risk of acquiring 73 
and spreading infectious diseases [6-8], especially respiratory diseases [9,10]. To minimize 74 
the spread of infections during the pilgrimage or in the pilgrims’ home countries upon their 75 
return, vaccination and non-pharmaceutical interventions are thus recommended by national 76 
and international public health agencies [11,12]. 77 
We carried out a systematic review of cohort and hospital studies that reported the prevalence 78 
of clinical symptoms of respiratory infections and pneumonia among pilgrims during the Hajj, 79 
and both their influenza and pneumococcal vaccination status, with the aim to provide data 80 
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allowing the investigation of the impact of this large mass-gathering event on public health 81 
policies and services and to identify potential targets for preventive measures. 82 
Search Strategy and Selection Criteria 83 
This review was performed according to Preferred Reporting Items for Systematic Reviews 84 
and Meta-Analyses (PRISMA) guidelines (http://www.prismastatement.org). 85 
The MEDLINE/PubMed and Scopus databases were searched for all relevant papers 86 
published prior to February 2018, using the terms: 87 
#1: Hajj OR hadj OR pilgrim OR pilgrims OR pilgrimage 88 
#2: Respiratory 89 
#3: Infection OR infections 90 
#4: ILI OR URTI OR URTIs OR URI OR URIs OR LRTI OR LRTIs OR LRI OR LRIs 91 
#5: Pneumonia OR Streptococcus pneumoniae OR pneumococcus OR pneumococcal 92 
#6: #1 AND ((#2 AND #3) OR (#4) OR (#5)) 93 
In addition, the Saudi epidemiology bulletin (http://seb.drupalgardens.com/) was hand 94 
searched for additional papers for inclusion. Finally, the reference lists of reviewed articles 95 
were searched for additional relevant papers. 96 
For inclusion, the article had to meet the following criteria: (1) Original study involving Hajj 97 
pilgrims; (2) detailed description of the study population, including influenza and 98 
pneumococcal vaccination status when available; (3) clinical or self-reported respiratory 99 
symptoms and diseases. Only articles published in English were included for review. We 100 
excluded cohort studies with less than 50 participants and case reports. We also excluded 101 
studies conducted among selected groups of individuals suffering from respiratory tract 102 
infections, due to lacking denominator data. 103 
The two authors independently performed the searches, screened titles/abstracts for eligibility, 104 
selected papers that appeared to be relevant according to the review's inclusion criteria, and 105 
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reviewed each of the selected manuscripts in full. The data were extracted from the included 106 
papers by one reviewer (SB) and collected in the summary table that was included in the 107 
review. The extracted data were checked by the two authors (SB and PG) for accuracy. Minor 108 
discrepancies were resolved by the authors′ discussion. 109 
Results 110 
Included studies 111 
The search strategy initially yielded 391 records, of which 143 were duplicates. Twenty-nine 112 
additional papers were identified through manual searches. Of the 277 papers identified 183 113 
records were excluded after screening the title and abstract. Of the 94 full text articles 114 
reviewed, 61 were deemed suitable for inclusion in this review according to the 115 
inclusion/exclusion criteria. The results of the search strategy are shown in Figure 1. 116 
Cohort studies addressing the prevalence of respiratory tract infections among Hajj 117 
pilgrims 118 
A total of 45 publications were identified. These studies were conducted among cohorts of 119 
pilgrims from the 1999 through the 2015 Hajj seasons. The results of these studies are 120 
presented in Table 1. Various study designs were used, including cross-sectional studies, case-121 
control studies, and prospective cohort studies with follow-up of pilgrims, before, during and 122 
after the Hajj. Participants were from different countries and continents (Africa, North 123 
America, Asia, Europe, as well as from Australia), with the majority from Iran, and they were 124 
recruited from different settings, including travel medicine clinics, vaccination centers, Hajj 125 
travel agencies, international airports and transit zones, Mecca's city and Mina encampments. 126 
Their numbers varied widely in these studies, ranging from 106 to 107,074. 127 
Respiratory symptoms were common during the Hajj. Overall, the prevalence of cough 128 
ranged from 1.9% in domestic and international pilgrims in 1999 [13] to 91.5% in Malaysian 129 
pilgrims in 2007 [14,15] (Table 3). More recent studies, conducted in different populations of 130 
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pilgrims during the 2011-2014 Hajj seasons, reported prevalence of cough ranging from 131 
46.3% to 86.8% [16-24]. These studies also reported a comparable prevalence of sore throat 132 
ranging from 34.7% to 91% among pilgrims [16-23]. 133 
In addition, many of these studies have investigated the epidemiology of respiratory tract 134 
infections among pilgrims by estimating the common prevalence of upper respiratory tract 135 
infection (URTI), acute respiratory infection (ARI) or influenza-like illness (ILI), which were 136 
inconsistently defined across studies by a combination of general symptoms (e.g. cough, sore 137 
throat and fever). Overall prevalence of ILI varied in these studies from 8% to 78.2% [14-138 
16,18-23,25-45] (Table 3). In large studies conducted among Iranian pilgrims between 2003 139 
and 2005, the prevalence of ILI was, respectively, 70.1% and 35.8% in 2003 and 2004 140 
[41,42], but 19.6% in 2005 [46]. In another large 5-year (2004-2008) follow-up study 141 
conducted among 254823 Iranian pilgrims, only 10.7% of pilgrims complained of ILI during 142 
the Hajj [47,48]. However, the ILI syndromic case definition used in the 2003-2004 study (ILI 143 
was defined as cough and fever of more than 38°C with or without the coryzal symptoms and 144 
myalgia) [41,42] was different with that used in the 2004-2008 study (ILI was defined as 145 
symptoms and signs such as sudden headache, dry cough, high grade fever, myalgia, coryza, 146 
malaise and loss of appetite with an abnormal general appearance) [47,48]. Also, it is unclear 147 
from the 2005 study [46] if the definition used was consistent with those used in the two 148 
previous studies [41,42,47,48]. In a recent large study, conducted among 3364 Egyptian 149 
pilgrims between 2012 and 2015, the prevalence of ILI was 30.4% (ILI was defined according 150 
to the World Health Organization definition as the presence of measured fever of ≥ 38 C°, and 151 
cough; with onset within the last 10 days) [45]. Other studies of different sizes (from 129 to 152 
468) and design were conducted from 2007 through 2014 among different populations of 153 
pilgrims using a common ILI definition (the association of cough, sore throat, and subjective 154 
fever). These studies have shown variable results, with overall rates of ILI ranging from 8% to 155 
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78.2% [14-16,18,19,21-23,25-26,31,35,37]. Thus, during the 2013 Hajj season, while the 156 
highest prevalence of ILI was observed among Malaysian pilgrims, with a prevalence 157 
estimated at 78.2% [25], a lower prevalence was observed among French pilgrims (47.3%) 158 
[18,21]. 159 
Coverage of seasonal influenza vaccination among pilgrims was evaluated in many studies, 160 
which have yielded varying results, with reported rates of influenza vaccination ranged from 161 
1.1% to 100% [14,15,18,21-23,25,26,28,29,31-34,36,37,41-51,53-56]. A variation over time 162 
in influenza vaccination coverage was observed, as exemplified by a rate of 10.5% observed 163 
in a survey of pilgrims from Riyadh in 2003 [43], but 94.4% in a similar survey in 2010 164 
[32,33,36]. During the 2013 Hajj season, influenza vaccination rates also varied according to 165 
pilgrims' country of origin [29], with 20% observed among Saudi pilgrims, 80% among 166 
Qatari pilgrims, and 87% among Australian pilgrims, while a study involving French pilgrims 167 
interestingly reported that none of them had received the 2013 influenza vaccine before 168 
departing for the Hajj because the vaccine was not available at this time [18,21]. The majority 169 
of the studies reported influenza vaccination coverage among pilgrims, but only 13 [18,19,21-170 
23,25,27,28,31,46-48,55] reported their pneumococcal vaccination status, with rates ranging 171 
from 1.2% among a multinational cohort of 1676 pilgrims from 13 countries (from Africa, 172 
Asia, USA and Europe) in 2013 [28] to 51.2% among a small study of 129 French pilgrims in 173 
2013 [18,21]. 174 
Hospital-based studies addressing the prevalence of respiratory tract infections among 175 
ill Hajj pilgrims 176 
Of the 61 publications that were included in this review, 16 specifically addressed ill Hajj 177 
pilgrims at health care facilities from 1993 through 2014 Hajj seasons. Medical facilities 178 
included primary health care centers (PHCCs) and different specialized wards in tertiary care 179 
hospitals, including ear, nose and throat (ENT) departments, intensive care units, emergency 180 
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units, infectious disease units and unspecified medical units. Pilgrim participants were 181 
included either as inpatients or outpatients. The results of these studies are summarized in 182 
Table 2. 183 
Overall, the prevalence of upper respiratory tract infections (URTI) ranged from 1.4% to 184 
42.1% (Table 3). This prevalence was 1.4% among 141 Pakistani pilgrims who attended the 185 
King Abdul Aziz hospital in Medina during the 1992 Hajj [57] and 42.1% among 3087 Saudi 186 
and non-Saudi patients (47.5% of them were pilgrims) who attended the ENT clinic at Al-187 
Noor Specialist Hospital in Mecca during the 2009 Hajj [58]. Pharyngitis was also frequently 188 
reported among ill pilgrims. Thus, in this study of 3087 pilgrims during the 2009 Hajj, the 189 
overall prevalence of pharyngitis was 45.7% [58]. More recently, in 2008, the prevalence of 190 
pharyngitis in a large cohort of 4136 outpatients patients from 82 nationalities who attended 191 
13 randomly selected Mina PHCCs (94.9% of whom were pilgrims) was found to be 23.7% 192 
[59,60], and 61% in a study of 1047 Saudi and non-Saudi patients (2.3% of them were 193 
inpatients) [61]. However, in this second study of 1047 patients, only 34.5% were pilgrims. 194 
On the contrary, lower prevalence rates of bronchitis were reported during the Hajj (1.4%-195 
9.6%) [59-63]. A recent retrospective cross-sectional multicenter study of 185 Turkish 196 
inpatients (87.5% were pilgrims) who returned to Turkey from the Arabian Peninsula 197 
countries between 2012 and 2014 reported a slightly higher prevalence of acute 198 
tracheobronchitis (13.6%) [64]. In addition, in this study, pneumonia was among the most 199 
common clinical diagnosis among the hospitalized Hajj patients and represented about half of 200 
diagnoses [64]. As pneumonia remains a major concern in critically ill patients, most of them 201 
reported the prevalence of pneumonia among pilgrims [57,59,60,62-71], with reported rates 202 
ranging from 0.2% in 2008 in 13 randomly selected Mina primary health care centers [59,60] 203 
to 54.8% in 2004 in two ICU in Mecca [68] (Table 3). The prevalence of pneumonia was not 204 
reported in 3 papers [58,61,72]. Pneumonia was the second most common admitting diagnosis 205 
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(22%) in a study of 140 patients admitted to the ICUs in four hospitals in Mina during the 206 
2004 Hajj [68]. This result is further confirmed by a recent study of 452 critically ill Hajj 207 
patients, of over 40 nationalities, admitted to 15 hospitals in 2009 and 2010. In this study, 208 
pneumonia was defined as the primary cause of critical illness (27.2%) of all ICUs admissions 209 
during the Hajj [65]. Also, in another prospective study of pilgrims admitted in two major 210 
ICUs in Mecca for the 2004 Hajj season, community acquired pneumonia (CAP) was the 211 
commonest source of sepsis, 54.8% [66]. 212 
Discussion 213 
The purpose of this review was to provide syndromic surveillance data that may be useful, in 214 
conjunction with microbiological data that will be presented in further papers, for the 215 
surveillance of respiratory infections and pneumonia during the Hajj. Despite the fact that 216 
some of the included studies in our review were performed among small numbers of pilgrims 217 
and cannot be extrapolated, it is clear from this work that respiratory symptoms have been 218 
common among Hajj pilgrims over the last 15 years, as evidenced by the high prevalence of 219 
cough (over 90%) among Malaysian pilgrims during the 2007 Hajj [73]. Cough is a common 220 
symptom among pilgrims [16,74] and likely results from crowded conditions during the Hajj. 221 
This close contact among such individuals may increase the risk of the transmission of 222 
respiratory pathogens, and therefore may contribute to respiratory disease outbreaks. Climatic 223 
conditions and air pollution in Mecca and surrounding holy sites during the Hajj [75] may 224 
also play a role. Recent follow-up studies thus evidenced a significant acquisition of 225 
respiratory viruses, particularly rhinovirus, influenza virus, and coronaviruses other than 226 
Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and of bacteria, including 227 
Streptococcus pneumonia, Hemophilus influenza, Staphylococcus aureus and Klesiella 228 
pneumonia by Hajj pilgrims upon their return from the Hajj [76,77]. Respiratory diseases are 229 
the most common diseases observed among pilgrims attending Mina primary health care 230 
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centers [59] and a major cause of hospital admission during the Hajj [70], with pneumonia a 231 
leading cause of admission to intensive care units [62,68], where they are responsible for 232 
about half of the cases of sepsis [66]. Unfortunately, while numerous articles on Hajj pilgrims 233 
were retrieved from our literature search, relatively few recent articles specifically addressed 234 
ill pilgrims in the context of hospital settings. The use of cohort studies allows investigators to 235 
evaluate the actual incidence of clinical events in Hajj pilgrims since it provides a 236 
denominator, but may not identify and capture the prevalence of some underlying conditions 237 
and of severe forms of respiratory tract infections, which are more likely to be evidenced in 238 
hospital patient populations. Conversely, hospital studies use data that may be biased, 239 
frequently lacking denominator values, and so probably overestimating the occurrence of 240 
severe illness. Moreover, a hospital-based study will, by definition, not capture some minor 241 
illness cases that do not require hospitalization. 242 
The prevalence rates of cough, sore throat and subjective fever varied widely across the 243 
included studies. These differences may result from differences in study design that may lead 244 
to potential biases (for example bias related to the method of data collection, using either self-245 
report questionnaires or telephone interview), study period (with regards to the seasonality of 246 
respiratory viral infections), and rates of vaccination against seasonal influenza among study 247 
participants which may widely vary from one study to another, as described in this review. 248 
Thus, all data regarding the pilgrims, including demographic data, medical history, clinical 249 
data and information on vaccination status and compliance with non-pharmaceutical 250 
preventive measures, should be carefully collected by using standardized questionnaires. In 251 
addition, in the context of syndromic surveillance for respiratory pathogens, data regarding 252 
the pilgrim’s symptoms should be collected prospectively during face-to-face interviews by 253 
trained medical investigators who travel with the pilgrims. One important result of this review 254 
is the finding of a lack of consistency ILI syndromic case definitions across included studies. 255 
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Thus, in a 2003 study (that did not fulfill the inclusion criteria for this review) [78], of 1310 256 
Malaysian pilgrims who had a clinic visit for upper respiratory tract symptoms at five clinics 257 
during the 2000 Hajj, with the aim of determining influenza vaccine effectiveness against 258 
clinically defined ILI, 63% had ILI (defined as sore throat in combination with either 259 
temperature ≥38°C or cough) and 14% had influenza by the CDC definition (defined as 260 
measured fever [≥100°F (37.8°C)] and a cough and/or a sore throat). Only one of the studies 261 
reported here used the CDC definition of ILI or the WHO definition (an acute respiratory 262 
infection with measured fever of ≥38 C° and cough, with onset within the last 10 days) [45]. 263 
In his paper, Rashid et al. demonstrated the low sensitivity of the CDC criteria and proposed 264 
therefore the use of the triad of ‘cough, sore throat and subjective fever’ to clinically define 265 
ILI at the Hajj or other mass gatherings, since this new simple clinical case definition is more 266 
specific and sensitive than the CDC definition [79]. This definition was used over the last 267 
years by French [16,18,19,21-23,31,37], Malaysian [14,15,25], Indian [26] and Afghan [35] 268 
investigators leading cohort studies among Hajj pilgrims, thus allowing more reliable 269 
comparisons of findings between studies (Table 1). 270 
Respiratory diseases are a major concern during the Hajj. Non-pharmaceutical interventions 271 
(e.g., hand hygiene, wearing face masks, social distancing) are known to reduce the spread of 272 
respiratory viruses from person to person and are therefore recommended to pilgrims by 273 
public health agencies. Although hand hygiene compliance is high among pilgrims, face mask 274 
use and social distancing remain difficult challenges. Data about the effectiveness of these 275 
measures for preventing acute respiratory infections at the Hajj are limited, and results are 276 
contradictory, highlighting the need for future large-scale studies [80]. 277 
In addition to non-pharmaceutical interventions, vaccination against influenza is 278 
recommended for all Hajj pilgrims by the Ministry of Health of Saudi Arabia [11,12]. 279 
Differences in study design and heterogeneity in the ILI definition across studies make it 280 
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difficult to compare findings from different studies and inhibits the drawing of conclusions 281 
regarding the potential effects of this vaccination on related clinical symptoms of influenza 282 
disease. However, recent papers by Alqahtani et al. and Alfelali et al. found the influenza 283 
vaccine to be effective, respectively, against both laboratory-confirmed influenza [81] and 284 
clinical influenza [82]. As influenza vaccination is generally considered effective in reducing 285 
influenza-related infections, the Scientific Committee for Influenza and Pneumococcal 286 
Vaccination guidelines (SCIPV) thus recommends, in its recent guidelines, an influenza 287 
vaccination for all people, especially those at high risk, at least 2 weeks before the Hajj [83]. 288 
It also recommends, for the next Hajj seasons that will take place from June to September, the 289 
administration (prior to the Hajj) of the Southern Hemisphere influenza vaccine for pilgrims 290 
from the Southern Hemisphere (where influenza positivity rates are higher during this period). 291 
Furthermore, as the influenza vaccine is not expected to be available for pilgrims from the 292 
Northern Hemisphere before these next Hajj seasons, the SCIPV also recommends the 293 
administration of the Southern Hemisphere influenza vaccine for those pilgrims from the 294 
opposite hemisphere before the Hajj [83]. Because of the mismatching between circulating 295 
and vaccine strains that has frequently occurred since 2003 [84], Alfelali et al. recommends, 296 
when the composition of influenza vaccines differs and whenever logistically feasible, taking 297 
into consideration the dual vaccination of Hajj pilgrims with both the Southern and Northern 298 
Hemispheres’ vaccines. However, such strategy is impaired by the frequent unavailability of 299 
the Southern Hemisphere influenza vaccine in the Northern Hemisphere. The issue of 300 
influenza vaccine availability to match Southern and Northern hemispheres was discussed by 301 
the Saudi Ministry of Health in consultation with the WHO and it was recommended to use 302 
the available hemisphere strain as long as there is a match in circulating strains [85]. Despite 303 
the risk of acquisition of S. pneumoniae during the Hajj, there is currently no consistent 304 
guideline on the use of pneumococcal vaccine for Hajj pilgrims across pilgrim countries of 305 
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origin [86,87]. Thus, and because many of the Hajj pilgrims are elderly and have chronic 306 
illnesses and underlying risk conditions for which pneumococcal vaccination is recommended 307 
[86], the SCIPV also recommended, in its 2016 pneumococcal vaccination guidelines, 308 
pneumococcal vaccination of the at-risk population at the appropriate time before the Hajj, 309 
using the 2 types of pneumococcal vaccines that are currently available: the 23-valent 310 
polysaccharide pneumococcal vaccine (PPSV23) and the 13-valent conjugate vaccine 311 
(PCV13) [88]. However, it did not recommend providing a pneumococcal vaccine routinely 312 
to healthy persons aged less than 50 years, because of lack of evidence. In addition, it has 313 
been well demonstrated that the conjugate vaccine against S. pneumoniae targets the most 314 
virulent serotypes associated with Invasive Pneumococcal Diseases (IPD) that are also 315 
associated with antibiotic resistance [89]. These arguments reinforce the need for compliance 316 
with current recommendations for vaccinating at-risk Hajj pilgrims against IPD and influenza 317 
[89]. 318 
Respiratory tract infections, including influenza, continue to be a major concern during the 319 
Hajj. Both cohort- and hospital-based studies provide complementary data and potentially 320 
useful information, and both are therefore necessary to provide a complete picture of the total 321 
burden of respiratory diseases during this mass gathering. Large multinational follow-up 322 
studies are thus recommended for clinic-based syndromic surveillance, in conjunction with 323 
microbiological surveillance. Matched cohorts ensure better comparability across studies, 324 
particularly in terms of origin of pilgrims and possible travelling conditions. However, the 325 
study design and data collection procedures should be standardized, to facilitate reporting and 326 
to achieve comparability between studies. Furthermore, the definition of ILI, and of most 327 
common symptoms used to define respiratory infections (e.g., URTI), needs to be precisely 328 
defined and consistently used. Future studies need to address the potential effects of influenza 329 
and pneumococcal vaccine in the context of the Hajj pilgrimage. Moreover, because of the 330 
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mismatching between circulating and vaccine strains that has frequently occurred since 2003 331 
[84], Alfelali et al. recommends, when the composition of influenza vaccines differs and 332 
whenever logistically feasible, taking into consideration the dual vaccination of Hajj pilgrims 333 
with both the southern and northern hemispheres’ vaccines. However, such strategy is 334 
impaired by the frequent unavailability of the southern hemisphere influenza vaccine in the 335 
northern hemisphere. Despite the risk of acquisition of S. pneumoniae during the Hajj, there is 336 
currently no consistent guideline on the use of pneumococcal vaccine for Hajj pilgrims across 337 
pilgrim countries of origin [86,87]. Thus, and because many of the Hajj pilgrims are elderly 338 
and have chronic illnesses and underlying risk conditions for which pneumococcal 339 
vaccination is recommended [86], the SCIPV also recommended, in its 2016 pneumococcal 340 
vaccination guidelines, pneumococcal vaccination of the at-risk population at the appropriate 341 
time before the Hajj, using the 2 types of pneumococcal vaccines that are currently available: 342 
the 23-valent polysaccharide pneumococcal vaccine (PPSV23) and the 13-valent conjugate 343 
vaccine (PCV13) [88]. Also, it did not recommend providing a pneumococcal vaccine 344 
routinely to healthy persons aged less than 50 years, because of lack of evidence. 345 
Respiratory tract infections, including influenza, continue to be a major concern during the 346 
Hajj. Both cohort- and hospital-based studies provide complementary data and potentially 347 
useful information, and both are therefore necessary to provide a complete picture of the total 348 
burden of respiratory diseases during this mass gathering. Large multinational follow-up 349 
studies are thus recommended for clinic-based syndromic surveillance, in conjunction with 350 
microbiological surveillance. Matched cohorts ensure better comparability across studies, 351 
particularly in terms of origin of pilgrims and possible travelling conditions. However, the 352 
study design and data collection procedures should be standardized, to facilitate reporting and 353 
to achieve comparability between studies. Furthermore, the definition of ILI, and of most 354 
common symptoms used to define respiratory infections (e.g., URTI), needs to be precisely 355 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
16 
 
 
defined and consistently used. Future studies need to address the potential effects of influenza 356 
and pneumococcal vaccine in the context of the Hajj pilgrimage. 357 
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Table 1. Studies conducted among cohorts of Hajj pilgrims 
Hajj 
season 
Study population Study design Global prevalence of 
respiratory symptoms 
(%) 
Vaccination 
coverage (%) 
Study Ref. 
2013-
2015 
847 Chinese pilgrims Longitudinal survey conducted in 
returning Hajj pilgrims arriving at 
Xinjiang and Gansu airports, 
China 
Fever: 1.9% 
Sore throat or cough: 1.9% 
Influenza: 100% Ma et al., 2017 (BMC 
Infectious Diseases) 
[50] 
2014 148 Iranian pilgrims Follow-up seroepidemiological 
study among Hajj pilgrims 
returning to Yazd province, Iran 
Cough: 63% Not specified Rahimian et al., 2017 
(Respiratory 
Medicine) 
[24] 
2012-
2015 
3364 Egyptian pilgrims A cross-sectional survey among 
Hajj pilgrims at Cairo Airport, 
Egypt. Study based on face-to-face 
interview 
ILI1: 30.4% Influenza: 19.7% Refaey et al., 2017 
(Influenza Other 
Respi Viruses) 
[45] 
2013 468 Malaysian pilgrims Cross-sectional survey conducted 
in pilgrims recruited at a Hajj 
course at Universiti Sains 
Malaysia (USM), Kelantan, 
ILI2: 78.2% Influenza: 37.4% 
Pneumococcal: 
31.6% 
Hashim et al., 2016 (J 
Travel Med) 
[25] 
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Malaysia, at Hajj Building 
Complex, Malaysia and in Mecca, 
Saudi Arabia. Study based on 
post-Hajj self-questionnaires 
collected on return 
2013 839 African pilgrims Cross-sectional survey conducted 
in returning pilgrims recruited at 
the ”Hajj village” special area at 
Kotoka International Airport, 
Ghana. Study based on face-to-
face interview 
Cough: 70.7% 
Sore throat: 40.9% 
Elevated temperature: 
18.4% 
Runny nose or sneezing: 
18.13% 
Breathing difficulty: 
14.8% 
Not specified Annan et al., 2015 
(Trop Med Int 
Health) 
[17] 
2014 270 Indian pilgrims Cross-sectional survey conducted 
in pilgrims recruited at departure 
from Kempegowda International 
Airport, Bangalore, India. Study 
based on telephone interview on 
return 
ILI2: 66.3% Influenza: 1.1% Fatema et al., 2015 
(IJPMN) 
[26] 
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2012-
2014 
382 French pilgrims Longitudinal survey conducted in 
pilgrims recruited at a specialized 
Hajj travel agency, Marseille, 
France. Study based on medical 
evaluation during travel 
ILI2: 46.2% 
Cough: 80.9% 
Sore throat: 91.0% 
Rhinitis: 78.7% 
Hoarseness: 63.0% 
Myalgia: 48.3% 
Subjective fever: 47.3% 
Not specified Gautret et al., 2015 
(Travel Med Infect 
Dis) 
[16] 
2007 106 Malaysian pilgrims Longitudinal survey conducted in 
pilgrims enrolled in the National 
Pilgrim Management and Fund 
Board, Malaysia. Study based on 
follow-up during travel 
Cough (average of the 6 
weeks of stay): 39.5% 
Runny nose (average of 
the 6 weeks of stay): 
25.5% 
Sore throat (average of the 
6 weeks of stay): 18.5% 
Fever (average of the 6 
weeks of stay): 7.1% 
Influenza: 61.3% Hasan et al., 2015 (J 
Immigr Minor 
Health) 
[51] 
2013 1676 pilgrims (Paired cohort: 692 
pilgrims/ Nonpaired cohort: 514 
pilgrims at arrival and 470 
Cross-sectional survey (unpaired 
cohort) and longitudinal survey 
(paired cohort) conducted in 
ILI: 61.9% Influenza: 21.9% 
Pneumococcal: 
1.2% 
Memish et al., 2015 
(Clin Microbiol 
Infect) 
[28] 
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pilgrims at Mina) from 13 
countries 
(Africa/Asia/USA/Europe) 
pilgrims recruited on arrival at 
Jeddah airport. Study based on 
post-Hajj face-to-face interview 
conducted at Mina 
2011 
and 
2012 
3203 pilgrims (1590 pilgrims at 
the beginning of the Hajj and 1613 
pilgrims at the end of the Hajj) 
from 18 countries in Africa or 
Asia 
Cross-sectional survey conducted 
in pilgrims recruited at Mecca for 
the beginning-Hajj cohort and 
Mina for the end-Hajj cohort. 
Study based on face-to-face 
interview 
URTI during Hajj (for the 
end-Hajj cohort): 29.2% 
Influenza or 
pneumococcal4 
(beginning-Hajj 
cohort versus end-
Hajj cohort): 
45.8% versus 
76.7%, 
respectively 
Memish et al., 2015 
(Clin Microbiol 
Infect) 
[27] 
2011 164 Australian pilgrims Cross-sectional survey conducted 
in pilgrims recruited at Mina 
encampment. Study based on post-
Hajj face-to-face interview 
ILI3: 63.4% 
Cough: 46.3% 
Sore throat: 34.7% 
Fever: 23.8% 
Runny nose: 23.8% 
Sputum: 12.8% 
Muscle pain: 9.7% 
Not specified Barasheed et al., 
2014 (Infect Disord 
Drug Targets) 
[20] 
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Headache: 8.5% 
Shortness of breath: 2.4% 
2013 1038 pilgrims from Saudi Arabia, 
Australia and Qatar 
Cross-sectional survey conducted 
in pilgrims recruited at Mina 
encampment. Study based on post-
Hajj face-to-face interview 
ILI4: 11% 
Sore throat: 59% 
Cough: 40% 
Runny nose: 34% 
Influenza 
(Australian versus 
Qatari versus 
Saudi pilgrims): 
87% versus 80% 
versus 20%, 
respectively 
Barasheed et al., 
2014 (Virol Sin) 
[29] 
2013 129 French pilgrims Longitudinal survey conducted in 
pilgrims recruited at a specialized 
Hajj travel agency, Marseille, 
France. Study based on medical 
evaluation during travel 
ILI2: 47.3% 
Cough: 86.8% 
Sore throat: 82.9% 
Rhinorrhea: 72.1% 
Myalgia: 50.4% 
Fever: 49.6% 
Dyspnea: 21.7% 
Influenza: None 
in 2013 and 
44.2% in 2012 
Pneumococcal: 
51.2% 
Benkouiten et al., 
2014 (Emerg Infect 
Dis) 
Gautret et al., 2014 
(Emerg Infect Dis) 
[18, 21] 
2012 169 French pilgrims Longitudinal survey conducted in 
pilgrims recruited at a specialized 
Hajj travel agency, Marseille, 
ILI2: 47.3% 
Cough: 83.4% 
Sore throat: 79.7% 
Influenza: 45.6% 
Pneumococcal: 
35.9% 
Benkouiten et al., 
2014 (Clin Infect Dis) 
Benkouiten et al., 
[19, 22, 
23] 
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France. Study based on medical 
evaluation during travel 
Rhinorrhea: 68.5% 
Myalgia: 46.5% 
Feverishness: 45.4% 
Dyspnea: 19.6% 
2013 (Clin Infect Dis) 
Gautret et al., 2013 
(Clin Microbiol 
Infect) 
2006 295 Iranian pilgrims Longitudinal survey conducted in 
pilgrims recruited at a Hajj 
caravan. Study based on medical 
evaluation during travel 
Runny nose: 51.7% 
Dry coughs: 51.7% 
Hoarseness: 47.7% 
Yellowish-greenish 
sputum: 42.8% 
Nose congestion: 38.8% 
Purulent Post-Nasal 
Discharge: 35.5% 
Sore Throat: 34.2% 
Painful swallowing: 
23.8% 
Throat itch: 28.6% 
Fever: 26.8% 
Myalgia: 24.6% 
Feeling chills: 17.8% 
Influenza and 
pneumococcal: 
63.7% 
Influenza or 
pneumococcal: 
26.4% 
Neither: 6.4% 
Incomplete 
information: 3.5% 
Dabiran et al., 2014 
(Health) 
[55] 
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2004-
2008 
254823 Iranian pilgrims (30037 
pilgrims in 2004, 75676 in 2005, 
48678 in 2006, 71595 in 2007, and 
28837 in 2008) 
Longitudinal survey conducted in 
pilgrims recruited at 1352 Hajj 
caravans. Study based on medical 
evaluation during travel 
Common cold like illness 
(total): 47.1% 
ILI5 (total): 10.7% 
Influenza (2004 
versus 2005): 
75.2% versus 
88.3%, 
respectively 
Pneumococcal 
(2004 versus 
2005): 2.5% 
versus 8.9%, 
respectively 
Razavi et al., 2014 
(Med J Islam Repub 
Iran) 
Razavi et al., 2013 
(Med J Islam Repub 
Iran) 
Meysamie et al., 
2006 (Saudi Med J) 
[47, 48, 
46] 
2010 1507 pilgrims Longitudinal survey conducted in 
pilgrims recruited at primary 
health care centers in Riyadh, 
Saudi Arabia (for the mandatory 
pre-Hajj meningococcal 
vaccination). Study based on 
telephone interview on return 
URTI6: 53.1% Influenza: 94.4% Al-Jasser et al., 2013 
(East Mediterr Health 
J) 
Al-Jasser et al., 2012 
(Saudi Med J) 
Al-Jasser et al., 2011 
(Saudi Epidemiology 
Bulletin) 
[32, 33, 
36] 
2009 274 French pilgrims Longitudinal survey conducted in ILI2: 8.0% Influenza: 97.4% Gautret et al., 2013 [31, 37] 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
36 
 
 
pilgrims recruited at a travel 
medicine clinic of a university 
hospital, France (for the 
mandatory pre-Hajj 
meningococcal vaccination). Study 
based on telephone interview on 
return 
Cough: 48.5% 
Sore throat: 36.1% 
Rhinorrhea: 23.7% 
Sputum: 13.5% 
Subjective fever: 10.9% 
Myalgia: 9.5% 
Shortness of breath: 2.9% 
Voice failure: 2.9% 
Influenza 
A(H1N1): 5.8% 
Pneumococcal: 
31.4% 
(Travel Med Infect 
Dis) 
Gautret et al., 2011 (J 
Travel Med) 
2006 338 Iranian Pilgrims  Longitudinal survey conducted in 
pilgrims recruited at a Hajj and 
pilgrimage organization at 
Chaharmahal va Bakhtiari 
Province, Iran. Study based on 
post-Hajj face-to-face interview 
Cough: 70.0% 
Hoarseness: 53.6% 
Sore throat: 49.7% 
Coryza: 43.8% 
Wheezing: 43.5% 
Myalgia: 30.8% 
Dyspnea: 17.8% 
Not specified Imani et al., 2013 
(International Journal 
of Travel Medicine & 
Global Health) 
[52] 
2012 541 Australian pilgrims Cross-sectional survey conducted 
in pilgrims recruited at Mina 
encampment. Study based on post-
Hajj face-to-face interview 
AFRI7: 9% Not specified Rashid et al., 2013 
(Med J Aust) 
[30] 
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2009 186 US pilgrims Longitudinal survey conducted in 
pilgrims recruited at pretravel 
clinic for Hajj travelers in 
Minnesota, US, and Arab 
Community Center for Economic 
and Social Services at multiple 
settings, including mosques, 
community health clinics, and the 
Detroit Wayne County 
International Airport, in Michigan, 
US. Study based on post-Hajj 
face-to-face and telephone 
interview 
Cough: 30.1% 
Sneezing: 25.8% 
Sore throat: 15.6% 
Fever: 13.4% 
Congestion: 8.6% 
Breathing problems: 2.1% 
‘’Bronchitis’’8: 1.1% 
ILI9: 9.7% 
Influenza: 63.0% 
Influenza 
A(H1N1): 38.7% 
Balaban et al., 2012 
(J Travel Med) 
[34] 
2010 1659 Afghan pilgrims Longitudinal survey conducted in 
pilgrims recruited at four transit 
areas located next to the Kandahar, 
Balkh, Hirat and Kabul airports, 
Afghanistan. Study based on post-
Hajj telephone interview 
ILI2: 37.8% Not specified Saeed et al., 2012 (J 
Epidemiol Glob 
Health) 
[35] 
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2009 305 Iranian pilgrims Cross-sectional survey conducted 
in returning pilgrims recruited 
Shiraz Airport, Iran 
Fever: 11.1% 
Cough: 48.2% 
Sore throat: 46.2% 
Nasal symptoms: 60.6% 
Myalgia: 31.8% 
Influenza: 97.7% Ziyaeyan et al., 2012 
(Influenza Other 
Respir Viruses) 
[53] 
2010 1717 pilgrims Cross-sectional survey conducted 
in returning pilgrims recruited at 
King Abdulaziz International 
Airport, Jeddah 
Cough: 72.2% Influenza: 52.4% Maslamani et al., 
2011 (Saudi 
Epidemiology 
Bulletin) 
[54] 
2007 387 Malaysian pilgrims Cross-sectional survey conducted 
in returning pilgrims recruited at 
transit centers at Jeddah and 
Medina 
ILI2: 40.1 
Cough: 91.5% 
Runny nose: 79.3% 
Fever: 59.2% 
Sore throat: 57.1% 
Influenza: 72.9% Deris et al., 2010 (J 
Travel Med) 
Deris et al., 2010 
(Trop Biomed) 
[14, 15] 
2007 394 Malaysian pilgrims Cross-sectional survey conducted 
in returning pilgrims recruited at 
transit centers at Jeddah and 
Medina 
Cough: 90.1% 
Runny nose: 78.2% 
Fever: 58.4% 
Sore throat: 56.3% 
Not specified Deris et al., 2009 
(Saudi Med J) 
[73] 
2006 580 French pilgrims Longitudinal survey conducted in Cough: 60.6% Influenza: 34.3% Gautret et al., 2009 [49] 
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pilgrims recruited at a travel 
medicine clinic of a university 
hospital, France (for the 
mandatory pre-Hajj 
meningococcal vaccination). Study 
based on telephone interview on 
return 
Fever: 16.6% (Clin Microbiol 
Infect) 
2004 170 Iranian pilgrims Longitudinal survey conducted in 
pilgrims recruited to departure 
from Iran (details not provided). 
Study based on medical follow-up 
at Mina encampment 
Common cold10: 57.0% 
ILI11: 10.9% 
Not specified Razavi et al., 2007 
(IJCID) 
[38] 
2002 1027 domestic pilgrims Longitudinal survey conducted in 
pilgrims recruited at primary 
health care centers in Riyadh, 
Saudi Arabia (for the mandatory 
pre-Hajj meningococcal 
vaccination). Study based on 
telephone interview on return 
ARI12: 39.8% Not specified Choudhry et al., 2006 
(East Mediterr Health 
J) 
[39] 
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2004 995 pilgrims from Riyadh  Longitudinal survey conducted in 
pilgrims recruited from randomly 
selected Hajj groups in Riyadh, 
Saudi Arabia. Study based on 
post-Hajj telephone interview 
ARI13: 25.6% Not specified Abdin et al., 2005 
(Saudi Epidemiology 
Bulletin) 
[40] 
2003-
2004 
51100 Iranian pilgrims (32370 
pilgrims in 2003 and 18730 
pilgrims in 2004) 
Longitudinal survey conducted in 
pilgrims recruited at 180 Hajj 
caravans in 2003 / 110 caravans in 
2004. Study based on medical 
evaluation during travel 
ILI14 in 2003: 70.1% 
ILI14 in 2004: 35.8% 
Influenza (2003 
versus 2004): 
10.7% versus 
75.2%, 
respectively 
Razavi et al., 2005 
(Acta Medica Iranica) 
Razavi et al., 2004 
(Acta Medica Iranica) 
[41, 42] 
2003 115 UK pilgrims Longitudinal survey conducted in 
pilgrims recruited at East London 
Mosque, London, UK. Study 
based on medical evaluation after 
travel 
Respiratory symptoms: 
80.9% 
Influenza: 26.1% El Bashir et al., 2004 
(Emerg Infect Dis) 
[56] 
2003 1027 pilgrims from Riyadh Longitudinal survey conducted in 
pilgrims recruited at 10 randomly 
selected primary health care 
centers in Riyadh, Saudi Arabia 
ARI15: 39.8% Influenza: 10.5% Al-Mudameigh et al., 
2003 (Saudi 
Epidemiology 
Bulletin) 
[43] 
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(for the mandatory pre-Hajj 
meningococcal vaccination). Study 
based on telephone interview on 
return 
1999 412 domestic and international 
pilgrims 
Cross-sectional survey conducted 
in pilgrims recruited at Mina. 
Study based on post-Hajj self-
administered questionnaires 
Runny nose: 18.0% 
Cough: 14.0% 
Sore-throat: 12.0% 
Not specified Fatani et al., 2001 
(Saudi Epidemiology 
Bulletin) 
[13] 
1999 2070 Pakistani pilgrims Longitudinal survey conducted in 
pilgrims recruited in organized 
groups in Pakistan. Study based on 
medical evaluation during travel 
ILI16: 47.9% 
Documented fever 
≥38.8°C: 29.8% 
URTI17: 72.2% 
Influenza: 54% Qureshi et al., 2000 
(Vaccine) 
[44] 
1ILI was defined according to the presence measured fever of ≥ 38 C°, and cough; with onset within the last 10 days. 
2Influenza-like illness (ILI) was defined according to the presence of the triad of cough, subjective fever and sore throat. 
3ILI was defined as subjective (or proven) fever plus one respiratory symptom (e.g. dry or productive cough, runny nose, sore throat, shortness of breath). 
4ILI was defined as subjective (or proven) fever and at least one respiratory symptom such as cough, sore throat and rhinorrhea. 
5ILI was defined as symptoms and signs such as: sudden headache, dry cough, high grade fever, myalgia, coryza, malaise and loss of appetite with an abnormal general 
appearance. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
42 
 
 
6Upper respiratory tract infections (URTI) was defined as any person who reported having developed at least one of the constitutional symptoms (fever, headache, myalgia) 
and one of the local symptoms (running nose, sneezing, throat pain, cough with /or without sputum) after reaching Mecca for the Hajj or within 2 weeks from return to 
Riyadh. 
7Acute febrile respiratory infection (AFRI) was defined as the presence of subjective fever plus at least one respiratory symptom (cough, sore throat, runny nose or 
breathlessness). 
8Two travelers who reported ‘‘bronchitis’’ as a symptom were also included. 
9ILI was defined as fever plus sore throat and/or coughing. 
10Common cold was defined as sore throat with coryzal symptoms, and low grade fever. 
11ILI was defined as fever >38.5°C, myalgia, low back pain, coryzal symptoms and cough. 
12Acute respiratory infection (ARI) was defined as one of the constitutional symptoms (fever, headache, myalgia) along with one of the local symptoms (running nose, 
sneezing, throat pain, cough with/without sputum, difficulty breathing). 
13ARI was defined as any person suffering from at least one of the constitutional symptoms (fever, headache, myalgia) along with one of the local symptoms (runny nose, 
sneezing, throat pain, cough with/without Sputum, difficulty in breathing) developing after reaching Makkah for the Hajj. 
14ILI was defined as cough and fever >38°C with or without the coryzal symptoms and myalgia. 
15ARI was defined as any person suffering from at least one of the constitutional symptoms (fever, headache, myalgia) along with one of the local symptoms (runny nose, 
sneezing, throat pain, cough with/without Sputum, difficulty in breathing) developing after reaching Mecca for the Hajj. 
16ILI was defined as sore throat with either temperature ≥38.8°C or cough. 
17Cough or sore throat or rhinorrhea or muscle ache or headache. 
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Table 2. Studies conducted among ill Hajj pilgrims at health care facilities 
Hajj 
season 
Study population Recrutement Proportion of ill patients with 
respiratory symptoms globally 
(%) 
Proportion of ill 
patients with 
pneumonia (%) 
Study Ref. 
2012-
2014 
185 Turkish patients (87.5% 
were pilgrims) returning to 
Turkey from the Arabian 
Peninsula countries 
15 referral Turkish centers with 
infectious diseases departments 
(inpatients) 
URTI1: 33.1% 
Acute tracheobronchitis2: 13.6% 
Acute exacerbation of COPD3: 
8.9% 
50.3% Erdem et al., 
2016 (Eur J Clin 
Microbiol Infect 
Dis) 
[64] 
2008 4136 patients (94.9% were 
pilgrims) from 82 nationalities 
13 randomly selected Mina 
primary health care centers 
(outpatients) 
Common cold: 20.6% 
Pharyngitis: 23.7% 
Bronchitis: 9.6% 
Tonsillitis: 4.2% 
0.2% Alzahrani et al., 
2012 (J Infect 
Public Health) 
Alzahrani et al., 
2009 (Saudi 
Epidemiology 
Bulletin) 
[59, 60] 
2009-
2010 
452 pilgrims from over 40 
nationalities 
Intensive care unit of 15 
hospitals in Mecca, Mina, 
Arafat, and Medina (inpatients) 
Not specified 27.2% Mandourah et al., 
2012 (BMC Infect 
Dis) 
[65] 
2009 3087 Saudi and non-Saudi Ear, nose, and throat clinic at Al- Pharyngitis: 45.7% Not specified Alherabi et al., [58] 
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patients (47.5% were pilgrims) Noor Specialist Hospital, Mecca 
(mostly outpatients) 
URTI4: 42.1% 2011 (Saudi Med 
J) 
2008 1047 Saudi and non-Saudi 
patients (34.5% were pilgrims) 
Ear, nose, and throat clinic at Al-
Noor Specialist Hospital, Mecca 
(mostly outpatients) 
Pharyngitis: 61.0% 
URTI4: 18.6% 
Tonsillitis: 5.5% 
Otitis media: 2.2% 
Not specified Alherabi et al., 
2009 (Saudi Med 
J) 
[61] 
2004 165 pilgrims Two intensive care units (King 
Faisal Hospital and King Abdul 
Aziz Hospital) in Mecca 
(inpatients with sepsis) 
Not specified 54.8% Baharoon et al., 
2009 (Travel Med 
Infect Dis) 
[66] 
2007 2411 patients Emergency room of AI-Anssar 
Hospital and 4 primary health 
care centers in Medina (in and 
outpatients) 
Not specified 1% Al-Quwaidhi et 
al., 2008 (Saudi 
Epidemiology 
Bulletin) 
[67] 
2007 248 pilgrims Two randomly selected Mina 
hospitals (Mina al Tawarri & 
Mina El-Jesser) (outpatients) 
Cough: 28.2% 
Dyspnea: 27.4% 
Fever: 25.0% 
Running nose: 16.5% 
Chest pain: 15.3% 
Not specified Khamis et al., 
2008 (J Egypt 
Public Health 
Assoc) 
[72] 
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2004 140 patients (97.9% were 
pilgrims) 
Intensive care units in Mina and 
Arafat hospitals (inpatients) 
Respiratory failure: 5.0% 
Upper airway obstruction: 0.7% 
22.1% Madani et al., 
2007 (Ann Saudi 
Med) 
[68] 
2005 689 pilgrims from 49 countries Tertiary care hospital in Mina 
(inpatient medical departments) 
Dyspnea: 38.3% 
Chest pain: 24.8% 
Cough: 22.1% 
Fever: 19.2% 
26.0% Khan et al., 2006 
(Saudi Med J) 
[69] 
2003 575 patients (97.4% were 
pilgrims) 
Seven hospitals in Mina and 
Arafat (inpatient medical wards)  
URTI4: 4.7% 
Acute bronchitis: 1.7% 
29.4% Madani et al., 
2006 (Ann Saudi 
Med) 
[62] 
2002 160 patients Two hospitals in Arafat and two 
hospitals in Mina (in patient 
medical wards) 
URTI4: 3.1% 
Dyspnea: 53.0% 
Cough: 49.0% 
Fever: 47.0% 
Chest pain: 12.5% 
39.4% Al-Ghamdi et al., 
2003 (Saudi Med 
J) 
[70] 
1993 7676 pilgrims Emergency Department of Al-
Noor Hospital in Mecca (in and 
outpatients) 
Sore-throat: 6.8% 
Common cold: 6.0% 
URTI4: 4.4% 
Bronchitis: 3.7% 
2.0% Al-Harbi et al., 
2000 (J Family 
Community Med) 
[63] 
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Headache: 1.6% 
Cough: 1.2% 
1993 773 pilgrims King Abdul Aziz hospital in 
Medina (inpatient medical 
wards)  
URTI4: 7.1% 45.8% Yousuf et al., 
1995 (Ann Saudi 
Med) 
[71] 
1992 141 Pakistani pilgrims King Abdul Aziz hospital in 
Medina (inpatient medical 
wards) 
URTI4: 1.4% 
Acute bronchitis: 1.4% 
29.1% Yousuf et al., 
1993 (PJMR) 
[57] 
1Upper respiratory tract infection (URTI) was defined as an acute infection that includes tonsillitis, pharyngitis, laryngitis, sinusitis, otitis media, and the common cold. 
2Acute tracheobronchitis was defined as a patient with dry cough and/or low-grade of fever (< 38 °C), sub-sternal pain, and fatigue in the absence of opacities on chest X-ray. 
3Acute exacerbation of chronic obstructive pulmonary disease (COPD) was defined as an association with increased frequency and severity of coughing and/or shortness of 
breath and wheezing, increased amount of sputum production, and/or a change in appearance of sputum in a patient with COPD. 
4Was not defined. 
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Table 3. Prevalence of cough, influenza-like illness, upper respiratory tract infection and 
pneumonia reported in the included studies 
Symptoms Prevalence (%) Range (%) 
Cough (in cohorts of Hajj pilgrims) 1.9 
14.0 
30.1 
39.5 
40.0 
46.3 
48.2 
48.5 
51.7 
60.6 
63.0 
70.0 
70.7 
72.2 
80.9 
83.4 
86.8 
90.1 
91.5 
1.9-91.5 
Cough (in ill Hajj pilgrims at health care facilities) 1.2 
22.1 
28.2 
49.0 
1.2-49 
ILI1 (in cohorts of Hajj pilgrims) 8.0 
9.7 
11.0 
8.0-78.2 
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10.7 
10.9 
30.4 
35.8 
37.8 
40.1 
46.2 
47.3 
47.3 
47.9 
61.9 
63.4 
66.3 
70.1 
78.2 
URTI2 (in cohorts of Hajj pilgrims) 29.2 
53.1 
72.2 
29.2-72.2 
URTI2 (in ill Hajj pilgrims at health care facilities) 1.4 
4.4 
4.7 
7.1 
18.6 
33.1 
42.1 
1.4-42.1 
Pneumonia (in ill Hajj pilgrims at health care facilities) 0.2 
1.0 
2.0 
22.1 
26.0 
0.2-54.8 
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27.2 
29.1 
29.4 
39.4 
45.8 
50.3 
54.8 
1Influenza-like illness 
2Upper respiratory tract infection 
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Figure 1. Flow diagram 
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